Benzinga - U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session.
- Affimed N.V.. (NASDAQ: AFMD) shares dipped 39.2% to $1.24 after the company announced topline data from its Phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral T cell lymphoma.
- Adicet Bio, Inc. (NASDAQ: ACET) shares declined 37.2% to $10.85 after the company announced safety and efficacy data from its ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell NHL.
- Satixfy Communications Ltd. (NYSE: SATX) fell 23.4% to $15.15.
- Karyopharm Therapeutics Inc. (NASDAQ: KPTI) declined 21% to $3.68. Karyopharm announced presentation of updated Phase 1 selinexor data in patients with treatment-naïve myelofibrosis at ASH 2022.
- HUYA Inc. (NYSE: HUYA) dropped 16.3% to $2.9050. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- TAL Education Group (NYSE: TAL) fell 16% to $5.55.
- Baozun Inc. (NASDAQ: BZUN) dropped 15.3% to $4.91. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- DouYu International Holdings Limited (NASDAQ: DOYU) fell 14.9% to $1.2850. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- Fate Therapeutics, Inc. (NASDAQ: FATE) dropped 14.6% to $16.10. GT Biopharma and Fate Therapeutics presented preclinical data highlighting novel dual antigen targeting approach for the treatment of AML at ASH 2022.
- Dada Nexus Limited (NASDAQ: DADA) dropped 14% to $6.34. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- Kura Oncology Inc (NASDAQ: KURA) dropped 13.7% to $13.04. Kura Oncology presented updated clinical data from KOMET-001 trial of menin inhibitor ziftomenib at American Society Of Hematology Annual Meeting.
- UpHealth, Inc. (NYSE: UPH) fell 13.5% to $2.1180.
- Lufax Holding Ltd (NYSE: LU) declined 13.4% to $1.9909. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- Hello Group Inc. (NASDAQ: MOMO) dropped 13.2% to $7.75.
- Bilibili Inc – ADR (NASDAQ: BILI) dropped 12.2% to $22.32. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- Abcam PLC (NASDAQ: ABCM) dropped 11.5% to $13.74.
- Erasca Inc (NASDAQ: ERAS) fell 11.3% to $5.04. Erasca recently priced a 15,384,616 share offering at $6.50 per share.
- Allogene Therapeutics Inc (NASDAQ: ALLO) dropped 11.3% to $7.77 after B of A Securities downgraded the stock from Buy to Underperform and announced a $9 price target.
- IQIYI Inc – ADR (NASDAQ: IQ) fell 10.8% to $3.28. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
- OneConnect Financial Technology (NYSE: OCFT) dropped 10.1% to $6.96.
- RH (NYSE: RH) fell 8.1% to $252.15 after Goldman Sachs (NYSE:GS) downgraded the stock from Neutral to Sell.
- Community Health Systems Inc (NYSE: CYH) dipped 7.8% to $3.30.
- Tencent (HK:0700) Music Entertainment Group – ADR (NYSE: TME) fell 6.5% to $7.66. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
BitcoinDogecoin© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.